An absolute requirement, the dermatological safety
BIODERMA has always sought to reconcile perfect effectiveness and better tolerance for each skin type and each condition. In order to guarantee the greatest dermatological safety, BIODERMA products contain a very limited number of ingredients and optimally dosed active ingredients. Pre-empting the recommendations of the health authorities, BIODERMA tends to exclude all dermatologically questionable products. These commitments are reflected in a formulation charter that applies to all product developments and grounds their superiority in a scientific method. This uncompromising approach explains why BIODERMA products improve the skin's tolerance and help it be less reactive. That is why they all benefit from the DAF (Dermatological Advanced Formulation) patented natural complex.
The BIODERMA charter
The BIODERMA Charter is made up of, 8 exclusive principles
1. BIOLOGICAL patents
All BIODERMA products are formulated with teams of biologists and dermatologists. They rely on a biological mode of action that acts on the causes and consequences of the dermatological condition to correct it over the long term.
2. Skin TOLERABILITY
BIODERMA formulas improve the skin's tolerability and boost its resistance to its environment through the development of a unique patent: D.A.F., Dermatological Advanced Formulation.
3. DERMATOLOGICAL SAFETY
3 hard and fast rules for perfect effectiveness and better tolerance :
- use only ingredients that are strictly necessary,
- select optimal doses of the purest active ingredients,
- prefer molecules already found in the skin.
4. Scientifically RECOGNISED ACTIVE INGREDIENTS
The ingredients and components used by BIODERMA meet the two basic criteria for our formulas: biological effectiveness and dermatological safety.
5. Principle of precaution
BIODERMA tends to exclude dermatologically questionable products and ingredients: parabens, phthalates, formol, formaldehyde, etc..
6. Safety and efficacy tests
Each BIODERMA product adheres to the most rigorous recommendations issued by the health authorities and leading dermatology companies.
7. Clinical trials
All BIODERMA care products are subject to clinical studies undertaken under the supervision of expert dermatologists, allergologists and toxicologists. These studies are then published in reference scientific journals.
8. Total traceability
BIODERMA is committed to monitoring the origin and ensuring the total traceability of its components and products through compliance with the standards in force in the cosmetic industry.
Biology & Dermatology
BIODERMA, dermatological laboratory
A pioneer since the 1970s, BIODERMA has acquired unique expertise by placing biology at the service of dermatology. This original scientific approach relies first and foremost on knowledge of the skin and its biological mechanisms to formulate products directly inspired by them.
A single model: healthy skin
All BIODERMA research revolves around the study of healthy skin and its cells and imbalances. The skin speaks its own language and BIODERMA tirelessly seeks to understand it. It is subject to changes and environmental stresses. Therefore, diseases, medicated treatments, ageing and many other factors may affect its balance and cause it to malfunction. BIODERMA's approach involves reactivating the skin's natural resources to help it resist and recover its normal functions, which are those found in healthy skin.
A unique concept, biological mimetism
Based on total respect for the skin, BIODERMA products imitate its natural biological mechanisms through their components and their modes of action. To formulate them, BIODERMA selects the purest active ingredients, using molecules naturally found in the skin for better tolerance. Depending on the malfunction, BIODERMA products preserve, activate or restore the skin's natural processes.